ZInvestorHunting

Daniella Kranjac

Solo GP · New York, New York

US Angel

Named as the only individual (director) on the Form D for Avant Bio Fund II LP, a $57.5M venture fund (Dec 2024). Also a non-executive director at 3 startups that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

84/ 100
High Conviction AngelLatest deal Dec 2024
Deal VelocityLatest deal Dec 2024USA & Europe pipeline
Typical Check$575K–$1.7MPre-Seed / Seed
Primary FocusBiotech & PharmaPre-seed to Series B
Direct AccessWarm Intro Recommended1-click pitch match

Why Daniella Kranjac holds a 84/100 confidence score

  • Verified past startup investments on public record
  • Target check sizes calibrated between $575K–$1.7M
  • Clear domain thesis in Biotech & Pharma
  • Named as the only individual (director) on the Form D for Avant Bio Fund II LP, a $57.5M venture fund (Dec 2024). Also a non-executive director at 3 startups that filed Form D.

Building in Biotech & Pharma? See how well your pitch deck matches Daniella Kranjac’s thesis.

Check My Startup Fit

Verified investment track record

Named as the only individual (director) on the Form D for Avant Bio Fund II LP, a $57.5M venture fund (Dec 2024). Also a non-executive director at 3 startups that filed Form D.

Source: SEC Form D: Avant Bio Fund II LP (Dec 23, 2024) · 3 more sources

Stages
Pre-seed to Series B
Typical check (est.)
$575K–$1.7M
Verified deals
4 on file
Latest activity
Dec 2024
Pitch Readiness

Is Daniella Kranjac a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Daniella Kranjac back?

Biotech & Pharma

Verified investments & deal activity

4 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • Alpenglow Biosciences

    Board seat on the company's SEC filing · WA

    Mar 2024
  • Virica Biotech

    Board seat on the company's SEC filing · A6

    Jan 2024
  • Avant Bio Fund II LP

    Invested through a fund

    Aug 2023
  • Vernal Biosciences

    Board seat on the company's SEC filing · VT

    Jun 2023

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Daniella Kranjac

Founders raising in bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Joseph Fernandes

Syndicate lead · Austin, TX

99/100
$145K–$595KActive Sep 2026
AI & MLBiotech & PharmaCybersecurity+1
Ben Horowitz

Solo GP · Menlo Park, CA

99/100
$75K–$200KActive Sep 2026
AI & MLBiotech & PharmaCrypto & Web3+1
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
David Blivin

Solo GP · Santa Fe, NM

86/100
$800K–$2.4MActive Feb 2026
B2B SoftwareBiotech & PharmaClimate & Energy
Jeffrey Arnold

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
Paul Jun

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Daniella Kranjac and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.